-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Nuvectis Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q3 2024.
- Nuvectis Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.15M, a 29.4% increase year-over-year.
- Nuvectis Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$19.4M, a 13.3% increase year-over-year.
- Nuvectis Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$22.3M, a 16.6% decline from 2022.
- Nuvectis Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.1M, a 48.1% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)